ArticleGastro hep advances2023

Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD.

Hidenori Toyoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.